Lead exposure during synaptogenesis alters NMDA receptor targeting via NMDA receptor inhibition
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
N-methyl-D-aspartate receptor (NMDAR) ontogeny and subunit expression are altered during developmental lead (Pb2+) exposure. However, it is unknown whether these changes occur at the synaptic or cellular level. Synaptic and extra-synaptic NMDARs have distinct cellular roles, thus, the effects of Pb2+ on NMDAR synaptic targeting may affect neuronal function. In this communication, we show that Pb2+ exposure during synaptogenesis in hippocampal neurons altered synaptic NMDAR composition, resulting in a decrease in NR2A-containing NMDARs at established synapses. Conversely, we observed increased targeting of the obligatory NR1 subunit of the NMDAR to the postsynaptic density (PSD) based on the increased colocalization with the postsynaptic protein PSD-95. This finding together with increased binding of the NR2B-subunit specific ligand [3H]-ifenprodil, suggests increased targeting of NR2B-NMDARs to dendritic spines as a result of Pb2+ exposure. During brain development, there is a shift of NR2B- to NR2A-containing NMDARs. Our findings suggest that Pb2+ exposure impairs or delays this developmental switch at the level of the synapse. Finally, we show that alter expression of NMDAR complexes in the dendritic spine is most likely due to NMDAR inhibition, as exposure to the NMDAR antagonist aminophosphonovaleric acid (APV) had similar effects as Pb2+ exposure. These data suggest that NMDAR inhibition by Pb2+ during synaptogensis alters NMDAR synapse development, which may have lasting consequences on downstream signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535 · cited 3×
“During early development, NR2B-containing NMDARs predominate until a developmental switch occurs, resulting in the incorporation of the NR2A subunit (Monyer et al., 1994).”
BackgroundHeteromeric NMDA receptors: molecular and functional distinction of subtypes
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541
The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory.
Tsien, J. Z., Huerta, P. T., & Tonegawa, S. (1996) · Cell · doi:10.1016/s0092-8674(00)81827-9 · Cited by 1,782 · cited 2×
“…and memory, is the result of modifications in synapses as defined by patterns of neuronal activity and alterations in the function and trafficking of the NMDA receptor (NMDAR) subtype of excitatory amino acid receptors (Chen and Tonegawa, 1997; Pérez-Otaño and Ehlers, 2005; Tsien et al., 1996).”
BackgroundExtrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686 · cited 3×
“NR2A- and NR2B-containing NMDARs have differential MAPK signaling (Kim et al., 2005), pro-death or pro-life signaling (Soriano et al., 2008), and differential induction of nuclear gene expression (Hardingham et al., 2002).”
BackgroundSubunit-Specific NMDA Receptor Trafficking to Synapses
Barria, A., & Malinow, R. (2002) · Neuron · doi:10.1016/s0896-6273(02)00776-6 · Cited by 515 · cited 1×
“An alternative explanation to our findings is that a reduction in overall network activity induced by Pb2+ inhibition of the NMDAR prevents incorporation of the NR2A subunit in synaptic receptors (Barria and Malinow, 2002; Pérez-Otaño and Ehlers, 2005; Quinlan et al., 2004).”
BackgroundKim, M. J., Dunah, A. W., Wang, Y. T., & Sheng, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.031 · Cited by 494 · cited 2×
“NR2A- and NR2B-containing NMDARs have differential MAPK signaling (Kim et al., 2005), pro-death or pro-life signaling (Soriano et al., 2008), and differential induction of nuclear gene expression (Hardingham et al., 2002).”
BackgroundHomeostatic plasticity and NMDA receptor trafficking
Pérez-Otaño, I., & Ehlers, M. D. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.03.004 · Cited by 356
Chen, C., & Tonegawa, S. (1997) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.20.1.157 · Cited by 300
Cited by
Mechanism and Health Effects of Heavy Metal Toxicity in Humans
Azeh Engwa, G., Udoka Ferdinand, P., Nweke Nwalo, F., & N. Unachukwu, M. (2019) · Poisoning in the Modern World - New Tricks for an Old Dog? · doi:10.5772/intechopen.82511 · Cited by 712
Witkowska, D., Słowik, J., & Chilicka, K. (2021) · Molecules · doi:10.3390/molecules26196060 · Cited by 593
Karri, V., Schuhmacher, M., & Kumar, V. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.09.016 · Cited by 514
Clinical and molecular aspects of lead toxicity: An update
Mitra, P., Sharma, S., Purohit, P., & Sharma, P. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1408562 · Cited by 389
Cognitive Impairment Induced by Lead Exposure during Lifespan: Mechanisms of Lead Neurotoxicity
Ramírez Ortega, D., González Esquivel, D. F., Blanco Ayala, T., Pineda, B., Gómez Manzo, S., Marcial Quino, J., Carrillo Mora, P., & Pérez de la Cruz, V. (2021) · Toxics · doi:10.3390/toxics9020023 · Cited by 341
Metadata
- Authors
- Neal, A. P., Worley, P. F., & Guilarte, T. R.
- Venue
- NeuroToxicology
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 32
- Issue
- 2
- Pages
- 281-289
- ISSN
- 0161-813X (ISSN-L)
- OpenAlex
- W2027852574
- Cited by
- 124
- References
- 8
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.